Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02831101
Other study ID # CER 11-25, NAC 11-78
Secondary ID
Status Completed
Phase N/A
First received July 1, 2016
Last updated October 24, 2017
Start date February 2012
Est. completion date November 2015

Study information

Verified date October 2017
Source University Hospital, Geneva
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

We compared BIS values during propofol stepwise induction with or without concomitant sufentanil in patients ≥ 65 years .


Description:

Bispectral index (BIS) is widely used to estimate the depth of anesthesia. In clinical studies, a large variability of BIS has been observed. Several factors may be responsible for this inconsistency. We were able to show that in elderly patients (average age 78 years) receiving increasing doses of propofol alone a BIS values at loss of consciousness (LOC) were about 30% higher compared with young patients (average age 35 years). We showed also that in young patients (average age 48 years) the BIS values at LOC were significantly higher in those receiving sufentanil concomitantly with propofol compared with those who had received propofol alone. It remains unknown, however, whether these data from young surgical patients are applicable to a population of elderly patients. It may be argued that in the elderly receiving propofol, the impact of advance age was so important that any addition of an opioid would not further disturb the sedation-monitor balance. Alternatively, it may be expected that in the elderly receiving an opioid added to propofol the impact of both drugs on sedation will be additive and that previous observations from younger patients will be further exaggerated. The impact of advance age and presence or absence of sufentanil during propofol induction on BIS values at LOC was investigated in this trial.


Recruitment information / eligibility

Status Completed
Enrollment 71
Est. completion date November 2015
Est. primary completion date November 2015
Accepts healthy volunteers No
Gender All
Age group 70 Years to 87 Years
Eligibility Inclusion Criteria:

- Age =65 years

Exclusion Criteria:

- History of heart disease

- History of renal disease

- History of psychiatric

- Obesity

- Allergy to propofol or sufentanil

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Sufentanil
To evaluate, in the elderly, the impact of a concomitant administration of sufentanil during a step-wise propofol induction of anaesthesia on the depth of sedation measured using BIS and clinical sedation score.
Placebo
To evaluate presence or absence of strong opioid (sufentanil) on BIS values in the elderly during propofol induction until the loss of consciousness

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Geneva

Outcome

Type Measure Description Time frame Safety issue
Primary BIS at baseline BIS values in awake patient in supine position, eyes closed, quiet environment BIS values at baseline before administration of any study drugs
Primary BIS and sufentanil BIS values recorded after the steady state concentration was obtained and kept during 10min. BIS values 10 min after steady state concentration of sufentanil
Primary BIS and propofol Propofol was administrated step-wise by increasing concentration of 0.5mcg/ml (0.5, 1.0, 1.5 etc.). After each steady state that was kept during 5 min, BIS values were recorded BIS values after steady state concentration of propofol
Primary BIS and LOC BIS values were recorded at LOC, that was estimated using a OAA/S scale, a 0-5 point scale, 5 corresponds to a fully awake state, a score of 0 to a completely unresponsive state. A score <2 (absence of response to mild prodding or shaking was regarded as LOC. Blinded to study drug investigator evaluated all sedation scores. BIS values at loss of consciousness
See also
  Status Clinical Trial Phase
Recruiting NCT04502550 - Brain Networks and Consciousness
Completed NCT04901871 - Remimazolam Bolus for General Anesthesia Phase 3
Completed NCT02783846 - The Effects of Different Doses of Dexmedetomidine on Propofol Requirement for Loss of Consciousness Undergoing Bispectral Index: a Double-blinded, Placebo-controlled Trial N/A
Completed NCT02125214 - Alteration of Temporal Organization of EEG Microstate Sequences During Propofol-induced Loss of Consciousness N/A
Terminated NCT00143754 - Effect of Chronic Oral Hydration in Patients With Recurrent Unexplained Syncope Phase 3